|
59
|
258
|
3qtoH |
Thrombin inhibition by pyridin derivatives |
|
3
|
29
|
3qgnA |
The allosteric e*-e equilibrium is a key property of the trypsin fold |
|
51
|
255
|
3pmbB |
2.9 angstrom crystal structure of bovine thrombin in tetragonal spacegroup |
|
5
|
29
|
3p70A |
Structural basis of thrombin-mediated factor v activation: essential role of the hirudin-like sequence glu666-glu672 for processing at the heavy chain-b domain junction |
|
1
|
36
|
3pmhA |
Mechanism of sulfotyrosine-mediated glycoprotein ib interaction with two distinct alpha-thrombin sites |
|
3
|
29
|
3pmaA |
2.2 angstrom crystal structure of the complex between bovine thrombin and sucrose octasulfate |
|
8
|
30
|
3p6zA |
Structural basis of thrombin mediated factor v activation: essential role of the hirudin-like sequence glu666-glu672 for processing at the heavy chain-b domain junction |
|
52
|
256
|
3pmaB |
2.2 angstrom crystal structure of the complex between bovine thrombin and sucrose octasulfate |
|
66
|
259
|
3p70B |
Structural basis of thrombin-mediated factor v activation: essential role of the hirudin-like sequence glu666-glu672 for processing at the heavy chain-b domain junction |
|
18
|
102
|
3po1C |
Thrombin in complex with benzothiazole guanidine |
|
4
|
29
|
3pmbA |
2.9 angstrom crystal structure of bovine thrombin in tetragonal spacegroup |
|
65
|
259
|
3p6zB |
Structural basis of thrombin mediated factor v activation: essential role of the hirudin-like sequence glu666-glu672 for processing at the heavy chain-b domain junction |
|
27
|
147
|
3po1B |
Thrombin in complex with benzothiazole guanidine |
|
58
|
259
|
3pmhB |
Mechanism of sulfotyrosine-mediated glycoprotein ib interaction with two distinct alpha-thrombin sites |
|
7
|
27
|
3po1A |
Thrombin in complex with benzothiazole guanidine |
|
3
|
27
|
3p17L |
Thrombin inhibition by pyridin derivatives |
|
62
|
258
|
3p17H |
Thrombin inhibition by pyridin derivatives |
|
93
|
411
|
3nxpA |
Crystal structure of human prethrombin-1 |
|
58
|
257
|
3lu9B |
Crystal structure of human thrombin mutant s195a in complex with the extracellular fragment of human par1 |
|
3
|
44
|
3lu9A |
Crystal structure of human thrombin mutant s195a in complex with the extracellular fragment of human par1 |
|
58
|
257
|
3ldxH |
Discovery and clinical evaluation of rwj-671818, a thrombin inhibitor with an oxyguanidine p1 motif |
|
3
|
26
|
3ldxL |
Discovery and clinical evaluation of rwj-671818, a thrombin inhibitor with an oxyguanidine p1 motif |
|
3
|
30
|
3jz1A |
Crystal structure of human thrombin mutant n143p in e:na+ form |
|
21
|
80
|
3k65A |
Crystal structure of prethombin-2/fragment-2 complex |
|
55
|
259
|
3jz1B |
Crystal structure of human thrombin mutant n143p in e:na+ form |
|
3
|
29
|
3jz2A |
Crystal structure of human thrombin mutant n143p in e* form |
|
74
|
299
|
3k65B |
Crystal structure of prethombin-2/fragment-2 complex |
|
53
|
257
|
3jz2B |
Crystal structure of human thrombin mutant n143p in e* form |
|
54
|
258
|
3hk3B |
Crystal structure of murine thrombin mutant w215a/e217a (one molecule in the asymmetric unit) |
|
53
|
259
|
3hatH |
Active site mimetic inhibition of thrombin |
|
54
|
258
|
3hkiB |
Crystal structure of murine thrombin mutant w215a/e217a in complex with the extracellular fragment of human par1 |
|
3
|
43
|
3hk6A |
Crystal structure of murine thrombin mutant w215a/e217a (two molecules in the asymmetric unit) |
|
2
|
36
|
3hatL |
Active site mimetic inhibition of thrombin |
|
3
|
40
|
3hkiA |
Crystal structure of murine thrombin mutant w215a/e217a in complex with the extracellular fragment of human par1 |
|
3
|
30
|
3hk3A |
Crystal structure of murine thrombin mutant w215a/e217a (one molecule in the asymmetric unit) |
|
53
|
259
|
3hkjB |
Crystal structure of human thrombin mutant w215a/e217a in complex with the extracellular fragment of human par1 |
|
46
|
258
|
3hk6B |
Crystal structure of murine thrombin mutant w215a/e217a (two molecules in the asymmetric unit) |
|
3
|
31
|
3hkjA |
Crystal structure of human thrombin mutant w215a/e217a in complex with the extracellular fragment of human par1 |
|
3
|
28
|
3gicA |
Structure of thrombin mutant delta(146-149e) in the free form |
|
3
|
46
|
3gisA |
Crystal structure of na-free thrombin in complex with thrombomodulin |
|
56
|
259
|
3gisB |
Crystal structure of na-free thrombin in complex with thrombomodulin |
|
51
|
248
|
3gicB |
Structure of thrombin mutant delta(146-149e) in the free form |
|
1
|
27
|
3f68L |
Thrombin inhibition |
|
57
|
258
|
3f68H |
Thrombin inhibition |
|
3
|
27
|
3eq0L |
Thrombin inhibitor |
|
54
|
255
|
3eq0H |
Thrombin inhibitor |
|
48
|
257
|
3ee0B |
Crystal structure of the w215a/e217a mutant of human thrombin (space group p2(1)2(1)2(1)) |
|
3
|
42
|
3edxA |
Crystal structure of the w215a/e217a mutant of murine thrombin |
|
50
|
258
|
3edxB |
Crystal structure of the w215a/e217a mutant of murine thrombin |
|
3
|
27
|
3egkL |
Knoble inhibitor |
